It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Learn the core crypto basics and the key holdings a beginner should own, plus tips to manage risk and start a balanced portfolio.
25,015 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
A former U.S. soccer player has built a $20 billion-a-year tech company and now credits relentless resilience over na...
JPMorgan Chief Executive Jamie Dimon hints at a post-CEO second act that could include writing, teaching, and media p...
Greystone Real Estate Capital closes its second LIHTC-focused fund at 137 million, expanding its LIHTC equity to over...
A bold shift from a traditional hotel operator to AI-focused opportunities helped Ackman fuel outsized gains. Here’s ...
A high-profile stage moment reshaped Jelly Roll's narrative, but off-camera leaks can quietly alter financial outcome...
Joby Aviation is set to report Q4 2025 results after the market close tonight. Analysts will track revenue, cash burn...
A veteran mortgage executive leaves loanDepot to launch Trust One Financial, a new broker-focused lender backed by Ea...
If you plan to start Social Security at 62 while still working, your benefits may be reduced. This guide walks throug...
Netflix walks away from an $83 billion Warner Bros. deal, freeing capital for expansion and content, lifting the stoc...
Investors are watching codexis (CDXS) 2025 earnings closely to see if partnerships and enzyme platforms translate int...
A $1 million retirement portfolio anchors a stable income, but taxes, inflation and market shifts shape actual take-h...